We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Invitrogen Licenses Technology for Fluorescent microRNA Labeling Kits

By Labmedica staff writers
Posted on 11 Mar 2008
Print article
Using Genisphere Inc.'s (Hatfield, PA, USA) 3DNA dendrimer signal amplification technology, Invitrogen Corp. (Carlsbad, CA, USA) will become the exclusive provider of fluorescent microRNA (miRNA) microarray labeling kits, according to a new license agreement. Genisphere's technology is combined with Invitrogen's Alexa Fluor fluorescent dyes and commercialized in the new NCode rapid miRNA labeling system, which is available from Invitrogen.

Genisphere's 3DNA dendrimer technology is based on highly branched DNA structures serving as scaffolds for multitudes of fluorescent dyes. As a class, dendrimers are complex, branched molecules built from interconnected natural or synthetic monomeric subunits. A 3DNA dendrimer is constructed from DNA monomers, as the name "3DNA” indicates.

Each 3DNA monomer is composed of two DNA strands that share a region of sequence complementarily located in the central portion of each strand. When the two strands anneal to form the monomer the resulting structure has a central double-stranded "waist” bordered by four single-stranded "arms.” This waist plus arms structure comprises the basic 3DNA monomer.

"Our new kit accelerates the discovery of novel miRNA biomarkers by reducing the amount of time scientists must invest to detect miRNAs. In addition, we have increased sensitivity compared to alternative technologies, which can preserve precious samples,” said Peter Welch, director of research and development, gene expression profiling at Invitrogen. "Because miRNAs play a significant role in cancer and in the differentiation of stem cells, discoveries resulting from experiments in those areas could potentially expedite the diagnostics applications of miRNA biomarkers in disease.”


Related Links:
Genisphere
Invitrogen
Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.